Denne side blev automatisk oversat, og nøjagtigheden af ​​oversættelsen er ikke garanteret. Der henvises til engelsk version for en kildetekst.

EXtubationsrelaterede komplikationer - EXTUBE-undersøgelsen (EXTUBE) (EXTUBE)

19. oktober 2026 opdateret af: University Health Network, Toronto

EXtubation-relaterede komplikationer - en international observationsundersøgelse for at forstå virkningen og bedste praksis i operationsstuen og intensivafdelingen - EXTUBE-undersøgelsen

EXTUBE is an international, multicentre, prospective cohort study evaluating the incidence, risk factors, and outcomes of extubation-related complications and describing clinical practices related to extubation after general anesthesia or after critical illness in the operating room (OR), out of OR anesthesia location or intensive care unit (ICU).

Studieoversigt

Status

Rekruttering

Betingelser

Detaljeret beskrivelse

Globally, over 200 million people each year require extubation. While routinely performed, extubation is a skilled and potentially high-risk procedure that should be performed only when physiologic, pharmacologic, and contextual conditions are optimal. Complications at this stage of patient care can result in decreased oxygen delivery to the brain and body, sometimes leading to serious adverse events such as cardiac arrest, brain damage, or death. Indeed, one quarter of airway complications that result in death or brain death occur at the time of extubation.

Despite the frequency of extubation and the potential for life-threatening complications, there is a lack of systematic data on the rate and circumstances under which these severe complications occur. The limited data indicate 10-30% of extubations may lead to severe complications, depending on the population and outcome definition. However, the certainty of these estimates is severely limited because they are based on studies that are small, mostly single-center, based on clinician recall, only capture a small portion of extubation complications (e.g., malpractice claims), or do not reflect current clinical practice. In addition, most lack a denominator and exclude successful extubations, making estimates of actual complication rates and risk factors impossible.

There has been no large study of extubation techniques or adherence to guidelines, so procedural factors associated with complications must be elucidated. While adherence to clinical practice guidelines has not been formally evaluated, surveys show non-adherence to some best practices and considerable variation in practice, and data from audits and medicolegal claims show that lack of adherence to best practices is frequently at the root cause of severe adverse extubation outcomes, with half of the complications deemed preventable. Therefore, data on the frequency and nature of extubation complications, patient and procedural risk factors for complications, and guideline adherence rates are needed before these preventable events can be addressed.

EXTUBE (EXtubation related complications - an international observational study To Understand the impact and BEst practices in the operating room and intensive care unit) is an international, multicenter, prospective cohort study

The primary objective of this study is to estimate the incidence of immediate complications related to extubation in adult patients after general anesthesia and/or after critical illness. The secondary objectives are to determine: 1) the incidence of mild extubation complications; 2) patient- and procedure-related risk factors for extubation complications; 3) the association between extubation complications and outcomes until hospital discharge; and 4) the rate of adherence to extubation clinical practice guidelines.

Undersøgelsestype

Observationel

Tilmelding (Anslået)

3000

Kontakter og lokationer

Dette afsnit indeholder kontaktoplysninger for dem, der udfører undersøgelsen, og oplysninger om, hvor denne undersøgelse udføres.

Studiekontakt

Undersøgelse Kontakt Backup

Studiesteder

    • New South Wales
      • Sydney, New South Wales, Australien, 2065
        • Afsluttet
        • Royal North Shore Hospital
    • Victoria
      • Melbourne, Victoria, Australien, 3135
        • Afsluttet
        • Eastern Health - Maroondah Hospital
      • Melbourne, Victoria, Australien, 3156
        • Afsluttet
        • Eastern Health - Angliss Hospital
      • Melbourne, Victoria, Australien, 3076
        • Afsluttet
        • The Northern Hospital
      • Melbourne, Victoria, Australien, 3128
        • Afsluttet
        • Eastern Health - Box Hill Hospital
      • Melbourne, Victoria, Australien, 3084
        • Afsluttet
        • Austin Health - Austin Hospital
      • Melbourne, Victoria, Australien, 3079
        • Afsluttet
        • Austin Health - Heidelberg Repatriation Hospital
    • British Columbia
      • Surrey, British Columbia, Canada, V3V 1Z2
        • Afsluttet
        • Surrey Memorial Hospital
    • New Brunswick
      • Moncton, New Brunswick, Canada, E1C 4B7
        • Afsluttet
        • The Moncton Hospital
    • Ontario
      • North York, Ontario, Canada, M4N 3M5
        • Afsluttet
        • Sunnybrook Hospital
      • Saint Catharines, Ontario, Canada, L2S 0A9
        • Afsluttet
        • Niagara Health - Marotta Family Hospital
      • Toronto, Ontario, Canada, M5B 1W8
        • Afsluttet
        • St. Michael's Hospital
      • Toronto, Ontario, Canada, M5G 1X5
        • Afsluttet
        • Mount Sinai Hospital
      • Toronto, Ontario, Canada, M5G 2C4
        • Rekruttering
        • University Health Network - Toronto General Hospital
        • Kontakt:
        • Ledende efterforsker:
          • Matteo Parotto, MD, PhD
        • Kontakt:
        • Underforsker:
          • Alicia Grassi, MD
      • Toronto, Ontario, Canada, M5T 2S8
        • Afsluttet
        • University Health Network - Toronto Western Hospital
    • Quebec
      • Montreal, Quebec, Canada, H2X 0C1
        • Afsluttet
        • Centre hospitalier de l'Université de Montréal (CHUM)
      • Piedecuesta, Colombia
        • Afsluttet
        • Hospital Internacional de Colombia
      • Bath, Det Forenede Kongerige, BA1 3NG
        • Afsluttet
        • Royal United Hospitals Bath
      • Newcastle upon Tyne, Det Forenede Kongerige, NE7 7DN
        • Afsluttet
        • Freeman Hospital
    • Arizona
      • Tucson, Arizona, Forenede Stater, 85724-5114
        • Afsluttet
        • Banner University Medical Centre
    • Arkansas
      • Little Rock, Arkansas, Forenede Stater, 72205
        • Afsluttet
        • University of Arkansas for Medical Sciences
    • Florida
      • Gainesville, Florida, Forenede Stater, 32608
        • Afsluttet
        • University of Florida
    • Illinois
      • Chicago, Illinois, Forenede Stater, 60637
        • Afsluttet
        • The University of Chicago
    • Oregon
      • Portland, Oregon, Forenede Stater, 97239
        • Afsluttet
        • Oregon Health & Science University
    • Texas
      • Houston, Texas, Forenede Stater, 77030
        • Afsluttet
        • The University of Texas Health Science Center
      • Castlebar, Irland, F23 H529
        • Afsluttet
        • Mayo University Hospital
      • Cork, Irland, T12 DFK4
        • Afsluttet
        • Cork University Hospital
      • Dublin, Irland, D07 R2WY
        • Afsluttet
        • Mater Misericordiae University Hospital
      • Galway, Irland, H91 YR71
        • Afsluttet
        • Galway University Hospitals
      • Waterford, Irland, X91 ER8E
        • Ikke rekrutterer endnu
        • University Hospital Waterford
        • Kontakt:
        • Kontakt:
        • Ledende efterforsker:
          • Dulmi T Nawarathna, MBBS, MCAI, FCAI
        • Underforsker:
          • Sheeba Hakak, MBBS, FCARCSI, EDIC, HCM.
      • Kuwait City, Kuwait
        • Afsluttet
        • Amiri Hospital
      • Auckland, New Zealand, 1023
        • Afsluttet
        • Auckland City Hospital
      • Invercargill, New Zealand, 9812
        • Afsluttet
        • Southland Hospital
      • Rotorua, New Zealand, 3010
        • Afsluttet
        • Rotorua Hospital
      • Singapore, Singapore, 308433
        • Afsluttet
        • Tan Tock Seng Hospital

Deltagelseskriterier

Forskere leder efter personer, der passer til en bestemt beskrivelse, kaldet berettigelseskriterier. Nogle eksempler på disse kriterier er en persons generelle helbredstilstand eller tidligere behandlinger.

Berettigelseskriterier

Aldre berettiget til at studere

18 år og ældre (Voksen, Ældre voksen)

Tager imod sunde frivillige

Ingen

Køn, der er berettiget til at studere

Alle

Prøveudtagningsmetode

Sandsynlighedsprøve

Studiebefolkning

All adult patients (≥18 years old) undergoing extubation of an endotracheal tube (including index extubation and re-extubations) after general anesthesia in the OR, out of OR anesthesia location or ICU during the specified enrollment window (up to 4 weeks).

Beskrivelse

Inclusion Criteria:

  • Adult patients (≥18 years old)
  • Undergoing extubation of an endotracheal tube (including index extubation and re-extubations) after general anesthesia in the OR, out of OR anesthesia location or ICU
  • Undergoing extubation during the specified enrollment window

Exclusion Criteria:

  • Patients will be excluded if the extubation is performed in the context of withdrawal of life support measures,
  • Patients will be excluded if the extubation is performed for tracheostomy decannulation

For each patient who is not included, reasons for exclusion will be reported.

Studieplan

Dette afsnit indeholder detaljer om studieplanen, herunder hvordan undersøgelsen er designet, og hvad undersøgelsen måler.

Hvordan er undersøgelsen tilrettelagt?

Design detaljer

  • Observationsmodeller: COHORT
  • Tidsperspektiver: PROSPECTIVE

Hvad måler undersøgelsen?

Primære resultatmål

Resultatmål
Foranstaltningsbeskrivelse
Tidsramme
At least one of the following, occurring within 60minutes after extubation (composite outcome): i) Severe hypoxemia ii) Cardiac arrest iii) Need for airway management
Tidsramme: Within 60 minutes after the end of extubation

The primary outcome will be the occurrence of at least one of the following (composite outcome) occurring within 60 minutes after the end of extubation:

i) Severe hypoxemia (oxygen saturation as measured by pulse oximetry falls below SpO2 < 80% for > 5 minutes) ii) Cardiac arrest iii) Need for airway management (reintubation, insertion of a supraglottic airway, bag-mask ventilation).

Within 60 minutes after the end of extubation

Sekundære resultatmål

Resultatmål
Foranstaltningsbeskrivelse
Tidsramme
Difficult airway and complications related to airway management if reintubation is required
Tidsramme: Within 60 minutes after the end of extubation

Difficult airway (i.e., experienced difficulty by an experienced airway manager with any or all of laryngoscopy or tracheal intubation, supraglottic airway use, face-mask ventilation, or front-of-neck airway) and complications related to airway management (e.g., esophageal intubation) if reintubation is required

Within 60 minutes after the end of extubation
Planned and unplanned non-invasive respiratory support
Tidsramme: Within 60 minutes after the end of extubation

Planned and unplanned non-invasive respiratory support or high flow nasal cannula

Within 60 minutes after the end of extubation
Emergency front of neck airway
Tidsramme: Within 60 minutes after the end of extubation

Emergency front of neck airway should airway management be required after extubation

Within 60 minutes after the end of extubation
Cardiac arrhythmia requiring chemical or electrical treatment
Tidsramme: Within 60 minutes after the end of extubation

Cardiac arrhythmia requiring chemical or electrical treatment

Within 60 minutes after the end of extubation
Severe Hypotension
Tidsramme: Within 60 minutes after the end of extubation

Severe hypotension (systolic arterial pressure < 65 mmHg recorded at any time or systolic arterial pressure < 90 mmHg for > 30 minutes or new need/increase of vasopressor and/or fluid load > 15 mL/kg)

Within 60 minutes after the end of extubation
Severe Hypertension
Tidsramme: Within 60 minutes after the end of extubation

Severe hypertension (systolic blood pressure ≥180 mmHg and/or diastolic blood pressure ≥120 mmHg),

Within 60 minutes after the end of extubation
Pulmonary aspiration
Tidsramme: Within 60 minutes after the end of extubation

Aspiration of gastric contents (gastric contents inhaled into the larynx and the respiratory tract)

Within 60 minutes after the end of extubation
Barotrauma
Tidsramme: Within 60 minutes after the end of extubation

Pneumothorax/pneumo-mediastinum

Within 60 minutes after the end of extubation
Dental injury
Tidsramme: Within 60 minutes after the end of extubation

Dental injury (notable change to the patient's dentition attributable to extubation or to reintubation, should this be required)

Within 60 minutes after the end of extubation
Airways injury
Tidsramme: Within 60 minutes after the end of extubation

Airways injury (e.g., vocal cord damage, arytenoid dislocation

Within 60 minutes after the end of extubation
Mortality
Tidsramme: Within 7 days after extubation

In-hospital mortality

Within 7 days after extubation
Re-intubation
Tidsramme: Within 48 hours after extubation

Re-intubation within 48 hours of extubation

Within 48 hours after extubation

Samarbejdspartnere og efterforskere

Det er her, du vil finde personer og organisationer, der er involveret i denne undersøgelse.

Sponsor

Efterforskere

  • Ledende efterforsker: Matteo Parotto, MD, PhD, UHN

Datoer for undersøgelser

Disse datoer sporer fremskridtene for indsendelser af undersøgelsesrekord og resumeresultater til ClinicalTrials.gov. Studieregistreringer og rapporterede resultater gennemgås af National Library of Medicine (NLM) for at sikre, at de opfylder specifikke kvalitetskontrolstandarder, før de offentliggøres på den offentlige hjemmeside.

Studer store datoer

Studiestart (Faktiske)

14. april 2025

Primær færdiggørelse (Anslået)

1. december 2027

Studieafslutning (Anslået)

1. december 2027

Datoer for studieregistrering

Først indsendt

28. marts 2024

Først indsendt, der opfyldte QC-kriterier

3. juni 2024

Først opslået (Faktiske)

5. juni 2024

Opdateringer af undersøgelsesjournaler

Sidste opdatering sendt (Faktiske)

22. oktober 2026

Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier

19. oktober 2026

Sidst verificeret

1. august 2026

Mere information

Begreber relateret til denne undersøgelse

Andre undersøgelses-id-numre

  • 24-5811
  • 4850 (Anden identifikator: Clinical Trials Ontario - CTO)

Plan for individuelle deltagerdata (IPD)

Planlægger du at dele individuelle deltagerdata (IPD)?

INGEN

Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter

Studerer et amerikansk FDA-reguleret lægemiddelprodukt

Ingen

Studerer et amerikansk FDA-reguleret enhedsprodukt

Ingen

Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .